Literature DB >> 26590499

A team care model of cervical 
screening in a general practice.

Darryn Rennie1, Jennifer Boxsell, Kaye Pedretti.   

Abstract

BACKGROUND: Cervical screening reduces the incidence and mortality rate of cervical cancer. General practices have opportunities to increase screening rates by modifying the model of service provided.
OBJECTIVE: We provide an example of team-based cervical screening in a general practice and report the effectiveness of invitation letters for women with no record of a Pap smear. DISCUSSION: The practice sent invitation letters to women with no record of a Pap smear (or reason for not requiring one) to attend a visit to a women's health clinic comprising a visit to a GP of choice and then a nurse to perform the smear. Practice cervical screening data were collected over 45 months to investigate the impact of invitation letters. The quality of Pap smears performed by nurses was recorded. The biennial cervical screening rate improved by 11%. The percentage of women with no Pap smear recorded was reduced from 41.71% to 27.99%. The quality of the smears taken by the nurses was above the nationwide average. The data show that invitation letters contributed to improved cervical screening and that nurses were highly effective team members in the collection of Pap smears.

Entities:  

Mesh:

Year:  2015        PMID: 26590499

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  3 in total

1.  The application value of PAX1 and ZNF582 gene methylation in high grade intraepithelial lesion and cervical cancer.

Authors:  H Liang; G L Li; J Liu; M Fu; H Huang; K Zhao; Y Wei; J Xiao
Journal:  Clin Transl Oncol       Date:  2020-06-08       Impact factor: 3.405

2.  MiR-142 inhibits the development of cervical cancer by targeting HMGB1.

Authors:  Daqiong Jiang; Huiyan Wang; Zhuyan Li; Zhen Li; Xin Chen; Hongbing Cai
Journal:  Oncotarget       Date:  2017-01-17

3.  MiR-4524b-5p/WTX/β-catenin axis functions as a regulator of metastasis in cervical cancer.

Authors:  Tong Li; Wenjuan Zhou; Yimin Li; Yaqi Gan; Yulong Peng; Qing Xiao; Chunli Ouyang; Anqi Wu; Sai Zhang; Jiaqi Liu; Lili Fan; Duo Han; Yu Wei; Guang Shu; Gang Yin
Journal:  PLoS One       Date:  2019-04-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.